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Abstract: BACKGROUND This survey was focused on the provision of neurointerventional services, the
current practices of managing patients under COVID-19 conditions, and the expectations for the future.
METHODS Invitations for this survey were sent out as a collaborative effort of the European Society of
Minimally Invasive Neurological Therapy (ESMINT), the Society of NeuroInterventional Surgery (SNIS),
the Sociedad Iberolatinoamericana de Neuroradiologia Diagnostica y Terapeutica (SILAN), the Society
of Vascular and Interventional Neurology (SVIN), and the World Federation of Interventional and Ther-
apeutic Neuroradiology (WFITN). RESULTS Overall, 475 participants from 61 countries responded (six
from Africa (1%), 81 from Asia (17%), 156 from Europe (33%), 53 from Latin America (11%), and 172
from North America (11%)). The majority of participants (96%) reported being able to provide emer-
gency services, though 26% of these reported limited resources. A decrease in emergency procedures was
reported by 69% of participants (52% in ischemic and hemorrhagic stroke, 11% ischemic, and 6% hem-
orrhagic stroke alone). Only 4% reported an increase in emergency cases. The emerging need for social
distancing and the rapid adoption of remote communication was reflected in the interest in establishing
case discussion forums (43%), general online forums (37%), and access to angio video streaming for live
mentoring and support (33%). CONCLUSION Neurointerventional emergency services are available in
almost all centers, while the number of emergency patients is markedly decreased. Half of the participants
have abandoned neurointerventions in non-emergent situations. There are considerable variations in the
management of neurointerventions and in the expectations for the future.
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ABSTRACT
Background This survey was focused on the provision 
of neurointerventional services, the current practices of 
managing patients under cOViD-19 conditions, and the 
expectations for the future.
Methods invitations for this survey were sent out 
as a collaborative effort of the european society of 
Minimally invasive neurological Therapy (esMinT), 
the society of neurointerventional surgery (snis), the 
sociedad iberolatinoamericana de neuroradiologia 
Diagnostica y Terapeutica (silan), the society of 
Vascular and interventional neurology (sVin), and the 
World Federation of interventional and Therapeutic 
neuroradiology (WFiTn).
Results Overall, 475 participants from 61 countries 
responded (six from africa (1%), 81 from asia (17%), 
156 from europe (33%), 53 from latin america 
(11%), and 172 from north america (11%)). The 
majority of participants (96%) reported being able 
to provide emergency services, though 26% of these 
reported limited resources. a decrease in emergency 
procedures was reported by 69% of participants (52% 
in ischemic and hemorrhagic stroke, 11% ischemic, 
and 6% hemorrhagic stroke alone). Only 4% reported 
an increase in emergency cases. The emerging need 
for social distancing and the rapid adoption of 
remote communication was reflected in the interest 
in establishing case discussion forums (43%), general 
online forums (37%), and access to angio video 
streaming for live mentoring and support (33%).
Conclusion neurointerventional emergency services 
are available in almost all centers, while the number of 
emergency patients is markedly decreased. half of the 
participants have abandoned neurointerventions in non- 
emergent situations. There are considerable variations 
in the management of neurointerventions and in the 
expectations for the future.
The COVID-19 pandemic has caused an unpar-
alleled disruption of public life and confronted 
healthcare systems with challenges unprecedented 
in modern history. While pneumonia and multi- 
organ failure has been the primary focus, there have 
been early reports suggesting an increased inci-
dence of stroke secondary to large vessel occlusion 
in unusual populations.1 Moreover, likely due to a 
combination of a decline in the number of patients 
seeking medical attention due to fear of becoming 
infected, and the exhaustion of healthcare resources, 
the pandemic has brought widespread changes in 
the ability to perform urgent and time- sensitive 
interventions. In many regions, elective procedures 
were put on hold altogether, further broadening the 
impact on neurointerventional practices.
COVID-19 was declared a global pandemic by 
the WHO on March 11, 2020.2 At that time, anec-
dotal evidence and individual lessons gleaned were 
exchanged between practitioners and finally formal-
ized in mid to end April, 2020, when the Society 
of NeuroInterventional Surgery (SNIS),3 the Euro-
pean Society of Minimally Invasive Neurological 
Therapy (ESMINT),4 and the Society of Vascular 
and Interventional Neurology (SVIN)5 published 
individual recommendations and guidance state-
ments for the care of emergent neurointerventional 
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Figure 1 Number of responses per country.
Figure 2 Situation of neurointerventional services under COVID-19 in working patterns (A), treatment of endovascular emergency cases (B), case 
volume in emergency cases (C), and case volume in non- emergency procedures (D).
At the same time, this survey was conducted as a joint effort 
of five national and international societies in the field of neuro-
interventions. Key areas of the survey were the provision of 
neurointerventional services in general, the current practices of 
managing patients under COVID-19 conditions, and the take- 
away lessons and expectations for the future. The aim of this 
survey was to understand potential geographical differences in 
perceptions and management of the crisis. We hypothesized that 
there were considerable geographical differences in the impact 
of COVID-19 on neurointerventional service organizations 
worldwide.
METHODS
Invitations for participation in this anonymous online survey 
were sent out as a collaborative effort of the European Society 
of Minimally Invasive Neurological Therapy (ESMINT), the 
Society of NeuroInterventional Surgery (SNIS), the Sociedad 
Iberolatinoamericana de Neuroradiologia Diagnostica y Tera-
peutica (SILAN), the Society of Vascular and Interventional 
Neurology (SVIN), and the World Federation of Interventional 
and Therapeutic Neuroradiology (WFITN). Because the survey 
was anonymous, it is possible that several members of one team 
from one center answered the survey.
The survey questions (online supplementary appendix) were 
modified based on the learnings from an initial ESMINT survey 
(conducted mid- March 2020, n=136 participants) in a short but 
constructive discussion with the survey committee of SNIS. A 
more extensive agreement process with all the societies would 
have delayed the survey deployment. The survey results were 
collected between April 2 and April 20, 2020. The results are 
presented mainly as cumulative and relative data. Whenever 
statistical testing was done, a χ2 test was used with a p value of 
<0.05 considered to reveal a statistically significant difference. 
Countries were aggregated to regions (Africa, Asia, Europe, 
Latin America, and North America) and considered individually 
for the purpose of selected analyses only if five or more partici-
pants from that country provided answers.
RESULTS
Overall, 475 participants from 61 countries responded (six from 
Africa (1%), 81 from Asia (17%), 156 from Europe (33%), 53 
from Latin America (11%), and 172 from North America (36%) 
(figure 1).
Situation of Neurointerventional Services in General
Are you (the practitioner) coming into the hospital every day? 
Two hundred and fourteen participants (45%) reported to be 
working from their home office or are alternating between 
home office and the hospital, typically for a week at a time; 135 
(28%) of the participants reported doing mainly neurointerven-
tions, while 117 participants (25%) reported doing mainly other 
typical work, such as administrative work and diagnostic read-
ings. Only nine participants (2%) reported being re- deployed in 
the hospital for other tasks. There were clear differences in orga-
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Figure 3 Left: availability of protection equipment. Right: interest in different online tools to face future challenges with expected limited travel 
options. PAPR, powered air- purifying respirators.
Have you or any of your team contracted COVID-19 in 2020? 
Of all participants, 370 (78%) reported no COVID-19 infec-
tion among their team members, 98 (21%) had at least one team 
member infected, and seven (2%) were currently tested but with 
unknown results. The highest rates of infection were reported from 
Spain (16/37; 43%), the UK (5/12; 42%), and France (8/14; 36%).
Are you able to provide the usual service for emergencies (stroke, 
subarachnoid hemorrhage)? The overwhelming majority of partic-
ipants (96%) reported being able to provide emergency services, 
though 26% of these reported limited team and/or hospital 
resources. Only 2% of the participants reported suspension of 
emergency services altogether (figure 2).
Have you noticed a reduction in emergency cases? There was a 
decrease in emergency procedures in 69% of participants (52% in 
ischemic and hemorrhagic stroke, 11% ischemic, and 6% hemor-
rhagic stroke alone) (figure 2); 27% of the participants reported 
no significant changes and 4% reported an increase in emergency 
case load (n=19). Eleven of the participants (58%) reporting an 
increase were located in North America. Despite this, they repre-
sented a minority even within their region, with 70% of the centers 
in North America reporting a decrease in emergency case volume.
How do you deal with non- emergency procedures? Only 7% of 
the centers reported a regular or almost regular case volume of 
non- emergency procedures, with by far the highest such rate in 
Asian countries (39%) that were less affected during the period 
during which the survey was conducted. In 49% of the centers, 
non- emergency procedures were stopped completely. Urgent, non- 
emergency cases were still being performed in 32% of the centers.
Current Practices of Managing Patients
What kind of personal protection do you use for COVID+ or 
suspected cases? A regular face mask (with shield) as the sole 
protective measure was reportedly used by 95 participants (20%). 
A catheter lab dedicated for COVID+ patients was reported to be 
available for 125 participants (26%). N95 masks were available 
for 329 participants (69%), with considerable differences ranging 
from 47% in Europe to 90% in North America (figure 3). There 
was no statistically significant difference in the rate of COVID+ 
practitioners reported for teams without and with availability 
of specific protection measures such as angio labs dedicated for 
COVID+ (20% vs 22%, p=0.275), FP95 masks (19% vs 24%, 
p=0.169), and powered air- purifying respirators (PAPR; 20% vs 
24%, p=0.806). In fact, across the board, there was a tendency 
towards higher availability of such protective measures in centers 
with higher rates of infection.
Video consultations were used for connecting within the primary 
hospital (18%) and with other hospitals (11%). At least one type of 
video consultation was used by 21% of the participants. The rate 
of participants using such technology ranged from 0% (Africa) to 
37% (North America).
How do you manage anesthesia in your emergency proce-
dures? The most frequent approaches to anesthesia were to either 
routinely intubate all patients (41%), or to avoid intubation, 
unless the airway became compromised (36%). A more selective 
approach was followed by a minority, intubating only suspected 
and confirmed COVID+ patients (20% of centers) or else intu-
bating only confirmed COVID+ patients only (5%). There was no 
association between the rates of COVID+ observed in teams intu-
bating all patients routinely (43/197, 22%), as opposed to teams 
who only intubated when the airway was compromised (38/170, 
22%).
Expectations for Developments After the Pandemic
When do you expect to re- commence to full capacity with non- 
emergency procedures? The majority of participants (53%) expected 
to be going back to full case load in less than 3 months or to see 
no decrease in non- emergency procedures (2%). Overall, only 6% 
of the participants expected that it was going to take longer than 6 
months to get back to normal, and 3% were unable to provide any 
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Table 1 Countries with five or more survey participants with national infection rates and expectations on the time to re- commence to full capacity 
of non- emergency procedures
Survey participants COVID-19 infections* Expected duration to re- commence to full capacity (%)
Total (n) April 2, 2020 April 20, 2020 Not stopped <3 months 3–6 months 6–12 months >12 months Unclear
USA 166 74 145 0% 65% 30% 3% 0% 2%
Japan 41 2 9 5% 45% 31% 10% 2% 7%
Spain 37 238 426 0% 68% 27% 0% 0% 5%
Germany 22 78 177 0% 41% 41% 5% 14% 0%
Italy 18 192 302 0% 33% 61% 0% 0% 6%
Argentina 15 3 7 0% 80% 20% 0% 0% 0%
France 14 85 233 0% 50% 43% 0% 0% 7%
UK 12 45 188 0% 0% 83% 0% 0% 17%
Brazil 9 4 20 0% 44% 44% 0% 11% 0%
S. Korea 9 19 21 44% 11% 11% 22% 0% 11%
India 8 0 1 0% 88% 13% 0% 0% 0%
Australia 6 20 26 0% 0% 50% 50% 0% 0%
Canada 6 29 100 0% 50% 17% 0% 0% 33%
Chile 6 16 58 0% 17% 83% 0% 0% 0%
Portugal 6 90 210 0% 100% 0% 0% 0% 0%
Sweden 6 60 150 0% 17% 67% 17% 0% 0%
Turkey 6 22 111 0% 33% 33% 33% 0% 0%
Colombia 5 3 8 0% 80% 0% 20% 0% 0%
Switzerland 5 211 311 0% 20% 60% 0% 0% 20%
*Confirmed COVID-19 infections per 100 000 inhabitants at the beginning and end of survey period (source: https://coronavirus.jhu.edu/map.html).
to normalize within 3 months varied considerably, from 20% to 
88% (table 1).
Which methods of remote support would be suitable to you? 
Participants expressed most interest in secure case discussion 
forums (43%), an online community forum (37%), and 24/7 
access to angio video streaming for live discussion (33%). Prefer-
ences clearly differed between continents (figure 3). At least one 
of the methods of remote support was deemed suitable by 182 
participants (38%), two methods by 86 participants (18 %), three 
methods by 49 participants (10%), and four methods by 44 partic-
ipants (9%); and 114 participants (24%) reported no suitable 
method.
DISCUSSION
This survey, conducted between April 2 and April 20, 2020, 
provides a snapshot in the development of the COVID-19 
pandemic. Countries were in different phases of the pandemic, 
with resultant varying effects on healthcare systems, at the time 
the survey was performed. The results of this survey provide a 
broad picture of the current situation for countries affected by the 
COVID-19 pandemic and are not necessarily representative for the 
true conditions in each country. The data are estimates from the 
neurointerventional physician perspective and do not necessarily 
reflect quantitative case volumes.
Neurointerventional emergency service was being maintained 
according to the vast majority of the participants (96%), while the 
emergency case load was reportedly decreasing according to 69% of 
the participants, in most cases affecting both ischemic and hemor-
rhagic stroke. An absolute increase in emergency case volume was 
reported by 4% of the participants only. One logical explanation 
for the decrease is a reduced number of transfers from referring 
hospitals.6 Another factor might be patients’ fear at the prospect 
of coming to the hospital during the pandemic. This assumption 
is supported by the decreased number of patients presenting, in 
particular with minor strokes and transient ischemic attacks.6 At 
the same time longer onset- to- door and door- to- treatment times 
have been observed in patients with major strokes.6 The centers 
reporting a stable or even increasing case load may be the centers 
that remain open in their geographical area where others have 
seized their acute interventions and transfer patients to the major 
hub. A quantitative analysis of these data is ongoing in many 
centers and is expected to be published in the coming months.
Non- emergency procedures were stopped altogether in the 
centers of half of the participants worldwide. This rate was lowest 
in Asia (20%) with 51/81 responses coming from Japan and South 
Korea, where the infection rate was low among the population at 
the time of the survey. In- hospital acquisition of COVID-19 may 
represent a considerable problem.7 Urgent, non- emergency cases 
were abandoned by about half of the participants. Canceling or 
postponing urgent procedures could be detrimental to patients 
who have a higher risk of imminent stroke than they do of being 
harmed by potential nosocomial infection. Balancing the risks 
of a delayed therapy versus the risk of a potential nosocomial 
COVID-19 infection is a challenge. Communicating these consid-
erations to patients is likely to be even more difficult. Patients 
might avoid coming to the hospital out of fear, both for emergen-
cies and urgent procedures.
There are considerable differences in the availability of protec-
tive equipment and dedicated treatment areas (figure 3). Partici-
pants from North America report the highest rate of catheter labs 
dedicated for COVID-19 patients, the highest rate of availability 
of N95 masks and, by far, the highest rate of availability of PAPR. 
It is quite alarming that N95 masks were available for only about 
half of the participants in Europe. However, protective equipment 
availability can change rapidly. Interestingly, there was no asso-
ciation between the availability of protective equipment and the 
rate of COVID-19 infections among the neurointerventional team 
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of association, as such equipment might be made available where 
there is a sense of urgency based on an overall deteriorating situa-
tion, with rising population infection rates.
The majority of participants (52%) expected to go back to full 
case load in less than 3 months, while only 6% of participants 
expected that a lower case load would last longer than 6 months. 
North Americans were the most optimistic about the speed of 
recovery (table 1).
One major result of the COVID-19 pandemic and the need for 
social distancing is the rapid adoption of remote communication, 
particularly using conferencing tools. At least one type of video 
consultation was reportedly currently being used by 21% of the 
participants already, either within the hospital or to connect with 
other hospitals (11%). Thirty- three percent of participants from 
all societies were interested in having access to 24/7 remote physi-
cian support via a live streaming platform. The interest in this 
technology ranged from 24% in Asia to 51% in Latin America 
(figure 3). With the decrease in cases being performed, many 
programs have modified their coverage models to reduce resident 
exposure and risk, while also allowing for backup options should 
physicians fall ill or come under quarantine.8 Neurointerventional 
teams are typically small. Splitting them into alternating teams may 
result in having more senior or more junior team members in the 
hospital at any given time. A recent study confirmed the feasibility 
of remote mentoring of thrombectomy procedures.9 This tech-
nology could now prove instrumental in including senior advice 
and guidance in emergency situations. This may remain critical in 
the future, as travel options may remain limited for an extended 
period of time.
Limitations
Systematic bias could have been introduced both by the relatively 
high rate of responses from countries that were most affected (eg, 
Spain, table 1) and by the different success in activating the avail-
able neurointerventionalists in general. The responses by country 
were limited to fewer than five responses for two thirds of the 
countries. For this reason, the countries were aggregated by conti-
nent, even in the presence of a substantial heterogeneity among the 
countries within a continent. Many more survey questions could 
have been asked. Any survey is a trade- off between complexity 
and the number of participants willing to complete the survey. Our 
focus was to achieve a high number of responses and we expected 
that a more complex survey would have led to lower participation 
and to considerable sampling and non- response bias.
CONCLUSION
Neurointerventional emergency services are available in almost 
all centers at present, while the number of emergency patients is 
reportedly markedly decreased in the vast majority of the centers. 
Half of the participants have abandoned neurointerventions in 
non- emergent situations. There are considerable variations in 
the management of neurointerventions during the COVID-19 
pandemic and in the expectations for the future.
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